Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | +1.55% |
|
-12.08% | +122.03% |
21/05 | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis | CI |
21/05 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+122.03% | 4Cr | |
+15.82% | 12TCr | |
+20.35% | 11TCr | |
+17.47% | 2.6TCr | |
-25.31% | 1.94TCr | |
-19.51% | 1.59TCr | |
-19.67% | 1.51TCr | |
-46.87% | 1.51TCr | |
+62.55% | 1.49TCr | |
+6.34% | 1.39TCr |
- Stock Market
- Equities
- DRRX Stock
- News DURECT Corporation
- Insider Buy: Durect